I costi della sindrome metabolica

Keywords

Dyslipidemia, Medicine, Population, Metabolic syndrome, Blood pressure

References

• Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.Benedikt Herrmann, Cathleen E. Berg, Etresia Vogel — 2004
• Annuario statistico italianoIstituto centrale di statistica, Istituto nazionale di statistica — 1955
• Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.Khaled Nashar — 2004
• Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndromeGerald F. Watts, Dick C. Chan, P. Hugh R. Barrett — 2003
• Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.Katherine Esposito, Raffaele Marfella, Miryam Ciotola — 2004
• Dietary PUFA and the metabolic syndrome in Indian Asians living in the UKLouise M. Brady, Christine M. Williams, Julie A. Lovegrove — 2004
• The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study.John S. Green, Philip R. Stanforth, Tuomo Rankinen — 2004
• Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.Giuseppe Derosa, Arrigo F.G. Cicero, A. Gaddi — 2004
• Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.Donald B. Hunninghake, Christie M. Ballantyne, Darbie Maccubbin — 2003
• Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndromeDaad H. Akbar — 2003
• Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome.M Dumortier, F Brandou, Antonia Pérez‐Martin — 2003
• Association of the metabolic syndrome with both vigorous and moderate physical activity.K. L. Rennie, Noel McCarthy, Shoshanah Yazdgerdi — 2003
• Relationships between changes in abdominal fat distribution and insulin sensitivity during a very low calorie diet in abdominally obese men and women.David E. Laaksonen, Sakari Kainulainen, A Rissanen — 2003
• Long-term, randomized clinical trial of two diets in the metabolic syndrome and type 2 diabetes.Lynne W. Scott, Ashok Balasubramanyam, Kay T. Kimball — 2003
• Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance.Kevin C.J. Yuen, Nicholas J. Wareham, Jan Frystyk — 2004
• Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.Tzung‐Dau Wang, Wen‐Jone Chen, Jong‐Wei Lin — 2004
• Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.Jean‐Pierre Després, Isabelle Lemieux, Agnès Pascot — 2003
• Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndromeDustin S. Hittel, William E. Kraus, Eric P. Hoffman — 2003
• Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.Gerald F. Watts, P. Hugh R. Barrett, Juying Ji — 2003
• Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome.Marius Trøseid — 2004

Cited by

• Focus su DRG, tariffe e TUC (Tariffa Unica Convenzionale)Carlo Lucioni, Giovanni Aguzzi, Giovanni Fattore — 2006
• The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysisLudovica Borsoi, Patrizio Armeni, Gleb Donin — 2022

Related papers

• Prevalence and pattern of diabetic dyslipidemia in Indian type 2 diabetic patientsRakesh Parikh, Shashank Joshi, P. S. N. Menon — 2010
• Analysis of dyslipidemia for staffs at government departments of some towns in Wuling mountainsLuo Yuan-ha — 2013
• Study on the symptom of metabolic syndrome in the physical examination of healthy populationWang Jian-we — 2006
• High prevalence of obesity, dyslipidemia and metabolic syndrome in a rural area in PakistanZahid Naeem, Bjørgulf Claussen, Akhtar Hussain — 2008
• The role of dyslipidemia in metabolic syndrome in children and adolescentsWeifen Zhu — 2012
• The metabolic syndrome: Insulin resistanceNasser Mikhail — 2009
• Study of insulin status in metabolic syndrome in correlation with presence of other risk factorsSudhanshu Shekhar, Ram Singh, Md. Jawed Akhtar — 2016
• Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasisFrancesca Caroppo, Alfonso Galderisi, Laura Ventura — 2021
• Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study.Maria de Fátima Haueisen Sander Diniz, Alline Beleigoli, María Inês Schmidt — 2020